Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Zura Bio Limited is a clinical-stage biopharmaceutical company focused on developing innovative dual-pathway antibodies for autoimmune and inflammatory diseases. Its pipeline includes candidates targeting cytokines like IL-17, BAFF, IL-7, and IL-33, with potential to address unmet medical needs. The company leverages licensed technologies, collaborates with major pharma partners, and advances therapies through clinical trials aimed at broad immune modulation.
This description was generated via AI from an annual report. Updated about 1 year ago.